Senators Reintroduce Bill Requiring Price Disclosures in DTC Ads

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Congress Reintroduces Bills To Require Price Disclosures in DTC Ads

J.W. Schomisch

January 28, 2025 at 10:32 AM EST

Sens. Chuck Grassley, R-Iowa, and Dick Durbin, D-Ill., reintroduced the “Drug-price Transparency for Consumers (DTC) Act,” which would require price disclosures in direct-to-consumer (DTC) prescription drug advertisements. Durbin introduced the same bill in April 2023, and a companion bill was introduced in the House in October 2023. This year’s Senate bill is co-sponsored i... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Congress Reintroduces Bills To Require Price Disclosures in DTC Ads

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT